Campbell & Co Investment Adviser’s Adamas Pharmaceuticals ADMS Stock Holding History

Campbell & Co Investment Adviser’s Portfolio ADMS Stock Details ADMS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-29,500	Closed	-$145K	–	887
2021 Q3	$145K	Buy	+29,500	New	+$143K	0.05%	546

Campbell & Co Investment Adviser's ADMS Position: Q4 2021 in Review

Campbell & Co Investment Adviser sold out of Adamas Pharmaceuticals (ADMS) in Q4 2021, closing a stake of 29,500 shares — an estimated $145K sold.

Campbell & Co Investment Adviser first reported a position in ADMS in Q3 2021 and held it in 1 quarter. The position peaked at $145K in Q3 2021. 0 funds tracked by Wall St. Rank hold ADMS as of Q4 2021.

Campbell & Co Investment Adviser reported no remaining Adamas Pharmaceuticals position as of Q4 2021 after selling out during the quarter.
Campbell & Co Investment Adviser sold 29,500 Adamas Pharmaceuticals shares in Q4 2021, an estimated $145K.
Campbell & Co Investment Adviser first reported a position in Adamas Pharmaceuticals in Q3 2021 and held it in 1 quarter.
Campbell & Co Investment Adviser's Adamas Pharmaceuticals position peaked at $145K in Q3 2021.
0 funds tracked by Wall St. Rank held Adamas Pharmaceuticals as of Q4 2021.

Based on Campbell & Co Investment Adviser's 13F filing for Q4 2021, filed 10 Feb 2022.